Bio-Rad Laboratories, Inc.

NYSE:BIO

Medical - Devices

Healthcare
$370.17 -0.23%

-$0.65 today

Market cap
$9.95B
Beta
1.08
P/E (TTM)
45.4
EPS (TTM)
$6.26
52W Low $228.40High $343.12

Volume 0.46M

Average 0.38M

BIO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Bio-Rad Laboratories, Inc.NYSE: BIO

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 53.1%

Gross margin was 53.1% in Q2 FY2026, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 51.9%, down 0.9 pp year over year. Over 3 fiscal years it narrowed by 3.9 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
53.1%+0.9 pp QoQ
Last fiscal yearDec 2025
52.0%-1.7 pp YoY
LTMJun 2026
51.9%-0.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.1 pp——
1 year-1.7 pp——
3 years-3.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
52.0%
Year-over-year change
-1.7pp

Gross Margin vs competitors

How BIO compares with its peers on the latest reported figures

  • BIO's LTM Jun 2026 gross margin of 51.9% is the 4th highest of the 11 companies compared; the peer median is 47.5%.
  • Its year-over-year change of -0.9 pp is the 6th highest of 11, against a peer median of -0.4 pp.
  • Over three fiscal years its change of -3.9 pp compares with a peer median of -1.7 pp.
BIO Competitors Peer median
Gross Margin for BIO and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
DHRDanaher CorporationLTM Sep 202658.6% -2.7 pp+0.2 pp
RVTYRevvity, Inc.LTM Jul 202652.1% -1.9 pp-0.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
RGENRepligen CorporationLTM Jun 202651.1% +6.8 pp-9.8 pp
LABStandard BioTools Inc.LTM Mar 202648.3% -1.2 pp+12.0 pp
BRKRBruker CorporationLTM Jun 202646.7% -1.6 pp-5.7 pp
AZTAAzenta, Inc.LTM Sep 202644.2% -2.0 pp+9.2 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
PACBPacific Biosciences of California, Inc.LTM Mar 202637.1% +20.9 pp-6.5 pp
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 202634.6% +5.5 pp-62.9 pp
Peer median (excluding BIO) 47.5%-0.4 pp-1.7 pp

Competitors are the stored peer set for BIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.92B2.8B2.67B2.57B2.58B
Cost of Revenue1.28B1.23B1.24B1.19B1.24B
Gross Profit1.64B1.57B1.43B1.38B1.34B
Gross Margin56.1%55.9%53.4%53.7%52.0%
Research & Development260.64M256.89M247.43M295.9M256.9M
Selling, General & Admin877.12M827.83M841.7M814M819.9M
Operating Expenses1.14B1.08B1.09B1.11B1.08B
Depreciation & Amortization137.6M137.3M145.9M151.6M165.4M
EBITDA5.59B(4.53B)(654.8M)(2.14B)1.21B
EBITDA Margin191.2%-161.6%-24.5%-83.5%46.8%
Operating Income500.34M482.62M337.8M269M270.5M
Operating Margin17.1%17.2%12.6%10.5%10.5%
Interest Income18.9M58M100.9M82M95.5M
Interest Expense1.55M38.11M49.44M48.9M49M
Other Income / Expenses4.95B(5.19B)(1.19B)(2.61B)725M
Income Before Tax5.45B(4.7B)(850.1M)(2.34B)995.5M
Pre-Tax Margin186.4%-167.9%-31.8%-91.3%38.5%
Income Tax Expense1.19B(1.08B)(212.78M)(498.3M)235.6M
Net Income4.25B(3.63B)(637.32M)(1.84B)759.9M
Net Margin145.6%-129.5%-23.9%-71.9%29.4%
EPS (Basic)142.61(121.79)(21.82)(65.36)27.87
EPS (Diluted)140.83(121.79)(21.82)(65.36)27.87
Weighted Avg Shares29.83M29.79M29.21M28.21M27.26M
Weighted Avg Shares (Diluted)30.21M29.79M29.21M28.21M27.28M

Bio-Rad Laboratories, Inc.

NYSE:BIO

Intrinsic Alpha fair value

Locked

Current Price

$370.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.